See also
ˇ Show More
The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Novo Nordisk A/S, Consolidated Statement of Cash Flows
USD $ in millions, translated from DKK kr
| 12 months ended | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|---|---|
 |
Net profit for the year | |
|
|
|
|
|
Income taxes | |
|
|
|
|
|
Depreciation, amortization and impairment losses | |
|
|
|
|
|
Interest income and interest expenses, net | |
|
|
|
|
|
Share-based payment costs | |
|
|
|
|
|
Share of (profit) loss in associated companies | |
|
|
|
|
|
Reversals of non-cash income statement items | |
|
|
|
|
|
Increase (decrease) in provisions and retirement benefit obligations | |
|
|
|
|
|
Changes in non-cash balance sheet items | |
|
|
|
|
|
(Gains) losses from sale of property, plant and equipment | |
|
|
|
|
|
Unrealised (gain) loss from marketable securities | |
|
|
|
|
|
Other, including difference between average and year-end exchange rate, unrealised exchange (gain) loss etc | |
|
|
|
|
|
Other adjustments | |
|
|
|
|
|
Adjustments for non-cash items | |
|
|
|
|
|
Trade receivables | |
|
|
|
|
|
Other receivables and prepayments | |
|
|
|
|
|
Inventories | |
|
|
|
|
|
Trade payables | |
|
|
|
|
|
Other liabilities | |
|
|
|
|
|
Exchange rate adjustments | |
|
|
|
|
|
Change in working capital | |
|
|
|
|
|
Dividend received | |
|
|
|
|
|
Interest received | |
|
|
|
|
|
Interest paid | |
|
|
|
|
|
Income taxes paid | |
|
|
|
|
|
Net cash generated from operating activities | |
|
|
|
|
|
Proceeds from the divestment of ZymoGenetics, Inc. | |
|
|
|
|
|
Purchase of intangible assets and other financial assets | |
|
|
|
|
|
Proceeds from sale of property, plant and equipment | |
|
|
|
|
|
Purchase of property, plant and equipment | |
|
|
|
|
|
Net change in marketable securities | |
|
|
|
|
|
Net cash used in investing activities | |
|
|
|
|
|
Repayment of loans | |
|
|
|
|
|
Purchase of treasury shares, net | |
|
|
|
|
|
Dividends paid | |
|
|
|
|
|
Net cash used in financing activities | |
|
|
|
|
|
Exchange gains (losses) on cash and cash equivalents | |
|
|
|
|
|
Net cash generated from activities | |
|
|
|
|
|
Cash and cash equivalents at the beginning of the year | |
|
|
|
|
|
Cash and cash equivalents at the end of the year | |
|
|
|
|
| Item | Description | The company |
|---|---|---|
| Net cash generated from operating activities | The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. | Novo Nordisk A/S's net cash generated from operating activities increased from 2009 to 2010 and from 2010 to 2011. |
May 23, 2012